VRCA logo

Verrica Pharmaceuticals (VRCA)

Profile

Full Name

Verrica Pharmaceuticals Inc.

Ticker Symbol

VRCA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 15, 2018

Indexes

Not included

Website

http://www.verrica.com

Employees

71

Key Details

Price

$0.49(+2.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.57M(+47.66% YoY)

Annual EPS

-$1.48(0.00% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.49
VRCA price is $0.49

30-Day Relative Volume

0.60
VRCA 30-day relative volume is 0.60

Price Performance

Price Most recent change

+2.4%
VRCA price was up +2.4% on Apr 17, 2025

Price YTD change

-29.93%
VRCA price is down -29.93% since January 1st

Price 1-year change

-93.05%
VRCA price is down -93.05% year-on-year

Price 3-year change

-93.81%
VRCA price is down -93.81% over the past 3 years

Price Range

Price All-time high

$23.29
VRCA price is currently -97.89% below its historical high of $23.29

Price 3-year low

$0.38
VRCA price is currently +28.40% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.02M
VRCA market capitalization is $45.02 million

Market cap 3-year change

-79.34%
VRCA market capitalization is down -79.34% over the past 3 years

Market cap All-time high

$510.84M
VRCA market capitalization is currently -91.19% below its historical high of $510.84 million

Market cap sector rank

36.38%
VRCA market capitalization is higher than 36.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+116.36%
VRCA shares outstanding is up +116.36% year-on-year

Shares Outstanding 3-Year Change

+233.51%
VRCA shares outstanding is up +233.51% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.21
VRCA beta is -0.21

200-day SMA

$1.98
VRCA price is currently -75.22% below its 200-day simple moving average

50-day SMA

$0.59
VRCA price is currently -16.52% below its 50-day simple moving average

RSI

46.73
VRCA 14-day relative strength index is 46.73

Volume

0.60
VRCA 30-day relative volume is 0.60

ATR

$0.08
VRCA average true range is $0.08

10-day Historical Volatility

238.81%
VRCA 10-day historical volatility is 238.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.57M
VRCA annual revenue is $7.57 million

Revenue Analysts estimate

$16.25M
VRCA annual revenue is currently -53.45% lower than the consensus analysts' forecast

Revenue 1-year change

+47.66%
VRCA annual revenue is up +47.66% year-on-year

Revenue Sector rank

24.22%
VRCA annual revenue is higher than 24.22% of companies in Healthcare sector

EPS

EPS

-$1.48
VRCA annual earnings per share is -$1.48

EPS Analysts estimate

-$0.43
VRCA annual earnings per share is currently +247.42% higher than the consensus analysts' forecast

EPS 1-year change

0%
VRCA {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

45.82%
VRCA annual earnings per share is higher than 45.82% of companies in Healthcare sector

Profit

Gross profit

$4.83M
VRCA annual gross profit is $4.83 million

Gross margin

63.79%
VRCA annual gross profit margin is 63.79%

Operating profit

-$65.84M
VRCA annual operating income is -$65.84 million

Operating margin

-870.16%
VRCA annual operating profit margin is -870.16%

Net income

-$76.58M
VRCA annual net profit is -$76.58 million

Net margin

-1012.15%
VRCA annual net profit margin is -1012.15%

Expenses

Total expenses

$73.40M
VRCA annual total expenses is $73.40 million

Operating expenses

$70.66M
VRCA annual total operating expenses is $70.66 million

Cost of goods sold

$2.74M
VRCA annual cost of goods sold is $2.74 million

Selling, general & administrative expenses

$58.82M
VRCA annual SGA is $58.82 million

Depreciation and amortization

$1.27M
VRCA annual depreciation & amortization is $1.27 million

Interest expense

$9.41M
VRCA annual interest expense is $9.41 million

Income tax

-
VRCA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$67.17M
VRCA annual earnings before interest & taxes is -$67.17 million

EBITDA

-$65.90M
VRCA annual EBITDA is -$65.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$54.13M
VRCA annual total assets is $54.13 million

Non current assets

$2.96M
VRCA annual long term assets is $2.96 million

Current assets

$51.18M
VRCA annual total current assets is $51.18 million

Cash and cash equivalents

$46.33M
VRCA annual cash & cash equivalents is $46.33 million

Accounts receivable

$48.00K
VRCA annual accounts receivable is $48.00 thousand

Inventory

$2.46M
VRCA annual inventory is $2.46 million

Liabilities

Total liabilities

$63.99M
VRCA annual total liabilities is $63.99 million

Long term liabilities

$34.98M
VRCA annual total long term liabilities is $34.98 million

Current liabilities

$29.01M
VRCA annual total current liabilities is $29.01 million

Accounts payable

$1.90M
VRCA annual accounts payable is $1.90 million

Debt

Total debt

$45.94M
VRCA annual total debt is $45.94 million

Total debt 1-year change

+0.94%
VRCA annual total debt is up +0.94% year-on-year

Long term debt

$32.33M
VRCA annual long term debt is $32.33 million

Short term debt

$13.61M
VRCA annual short term debt is $13.61 million

Equity & Capital

Shareholders equity

-$9.86M
VRCA annual stockholders equity is -$9.86 million

Book value

-$9.86M
VRCA annual book value is -$9.86 million

Retained earnings

-$307.03M
VRCA annual retained earnings is -$307.03 million

Working capital

$22.17M
VRCA annual working capital is $22.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.93M
VRCA annual cash flow from operations is -$60.93 million

Cash from operations 1-year change

-57.94%
VRCA annual cash flow from operations is down -57.94% year-on-year

Cash from investing

-$19.00K
VRCA annual cash flow from investing activities is -$19.00 thousand

Cash from investing 1-year change

+94.75%
VRCA annual cash flow from investing activities is up +94.75% year-on-year

Cash from financing

$37.73M
VRCA annual cash flow from financing activities is $37.73 million

Cash from financing 1-year change

-49.16%
VRCA annual cash flow from financing activities is down -49.16% year-on-year

CAPEX

CAPEX

$27.00K
VRCA annual capital expenditures is $27.00 thousand

CAPEX 1-year change

-92.54%
VRCA annual capital expenditures is down -92.54% year-on-year

Free Cash Flow

Free cash flow

-$60.95M
VRCA annual free cash flow is -$60.95 million

Free cash flow 1-year change

-56.54%
VRCA annual free cash flow is down -56.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

63.79%
VRCA annual gross profit margin is 63.79%

Operating margin

-870.16%
VRCA annual operating profit margin is -870.16%

Net margin

-1012.15%
VRCA annual net profit margin is -1012.15%

ROA & ROE

ROA

-112.84%
VRCA annual return on assets is -112.84%

ROE

-1546.58%
VRCA annual return on equity is -1546.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VRCA price to earnings ratio value is unknown

PE ratio Sector rank

-
VRCA price to earnings ratio is unknown

PB Ratio

PB ratio

-4.57
VRCA price to book ratio is -4.57

PB ratio Sector rank

4.04%
VRCA price to book ratio is higher than 4.04% of companies in Healthcare sector

PS Ratio

PS ratio

5.95
VRCA price to sales ratio is 5.95

PS ratio Sector rank

69.96%
VRCA price to sales ratio is higher than 69.96% of companies in Healthcare sector

Enterprise value

Enterprise value

$44.63M
VRCA enterprise value is $44.63 million

Enterprise value Sector rank

40%
VRCA enterprise value is higher than 40% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.68
VRCA EV/EBITDA is -0.68

EV/EBITDA Sector rank

48.04%
VRCA EV/EBITDA is higher than 48.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.76
VRCA annual current ratio is 1.76

Quick ratio

1.68
VRCA annual quick ratio is 1.68

Leverage

Debt to equity

-4.45
VRCA annual debt to equity ratio is -4.45

Interest coverage ratio

-7.14
VRCA annual interest coverage ratio is -7.14

Risk & Stability

Piotroski F-Score

3
VRCA piotroski f-score is 3

Altman Z-Score

-10.98
VRCA altman z-score is -10.98

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Hold
Apr 8, 25 HC Wainwright & Co.
Neutral
Mar 12, 25 Needham
Hold
Dec 20, 24 Needham
Hold
Nov 6, 24 HC Wainwright & Co.
Neutral
Nov 5, 24 RBC Capital
Sector Perform
Nov 5, 24 Needham
Hold
Oct 21, 24 TD Cowen
Buy
Oct 4, 24 RBC Capital
Outperform
Oct 3, 24 Needham
Hold

Institutional Ownership

Similar stocks

FibroBiologics (FBLG)
FBIO logo
Fortress Biotech (FBIO)
PRLD logo
Prelude Therapeutics Incorporated (PRLD)
IMMX logo
Immix Biopharma (IMMX)
ARMP logo
Armata Pharmaceuticals (ARMP)
IMRX logo
Immuneering (IMRX)
SKYE logo
Skye Bioscience (SKYE)
ZOM logo
Zomedica (ZOM)
MRSN logo
Mersana Therapeutics (MRSN)
  • What is the ticker symbol for Verrica Pharmaceuticals?
  • Does Verrica Pharmaceuticals pay dividends?
  • What sector is Verrica Pharmaceuticals in?
  • What industry is Verrica Pharmaceuticals in?
  • What country is Verrica Pharmaceuticals based in?
  • When did Verrica Pharmaceuticals go public?
  • Is Verrica Pharmaceuticals in the S&P 500?
  • Is Verrica Pharmaceuticals in the NASDAQ 100?
  • Is Verrica Pharmaceuticals in the Dow Jones?
  • When was Verrica Pharmaceuticals's last earnings report?
  • When does Verrica Pharmaceuticals report earnings?
  • Should I buy Verrica Pharmaceuticals stock now?

What is the ticker symbol for Verrica Pharmaceuticals?

The ticker symbol for Verrica Pharmaceuticals is NASDAQ:VRCA

Does Verrica Pharmaceuticals pay dividends?

No, Verrica Pharmaceuticals does not pay dividends

What sector is Verrica Pharmaceuticals in?

Verrica Pharmaceuticals is in the Healthcare sector

What industry is Verrica Pharmaceuticals in?

Verrica Pharmaceuticals is in the Biotechnology industry

What country is Verrica Pharmaceuticals based in?

Verrica Pharmaceuticals is headquartered in United States

When did Verrica Pharmaceuticals go public?

Verrica Pharmaceuticals's initial public offering (IPO) was on June 15, 2018

Is Verrica Pharmaceuticals in the S&P 500?

No, Verrica Pharmaceuticals is not included in the S&P 500 index

Is Verrica Pharmaceuticals in the NASDAQ 100?

No, Verrica Pharmaceuticals is not included in the NASDAQ 100 index

Is Verrica Pharmaceuticals in the Dow Jones?

No, Verrica Pharmaceuticals is not included in the Dow Jones index

When was Verrica Pharmaceuticals's last earnings report?

Verrica Pharmaceuticals's most recent earnings report was on Mar 11, 2025

When does Verrica Pharmaceuticals report earnings?

The next expected earnings date for Verrica Pharmaceuticals is May 13, 2025

Should I buy Verrica Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page